Oral premalignant lesions induce immune reactivity to both premalignant oral lesions and head and neck squamous cell carcinoma

By Young M.   Neville Brad   Chi Angela   Lathers Deane   Boyd Gillespie M.   Day Terry  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1077-1086

Springer Publishing Company

Access to resources Recommend Favorite

Retinoblastoma and p53 protein expression in pre-malignant oral lesions and oral squamous cell carcinoma

By          

Molecular Medicine Reports, Vol. 6, Iss. 1, 2012-01 ,pp. : 163-166

Spandidos Publications

Access to resources Recommend Favorite

Recovery of Immune Responsiveness in Lethally-irradiated Mice Protected with Syngeneic Marrow Cells

By Gregory Connie J.   Lajtha L.G.  

International Journal of Radiation Biology, Vol. 17, Iss. 2, 1970-03 ,pp. : 117-126

Informa Healthcare

Access to resources Recommend Favorite

Glucose Transporter-1 (GLUT-1) Immunoreactivity in Benign, Premalignant and Malignant Lesions of the Gallbladder

By Legan Mateja  

Pathology & Oncology Research, Vol. 17, Iss. 1, 2011-03 ,pp. : 61-66

Springer Publishing Company

Access to resources Recommend Favorite

Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group

By Kroiss Regina  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 10, 2008-10 ,pp. : 1113-1121

Springer Publishing Company

Access to resources Recommend Favorite